CREDO TECHNOLOGY GROUP HOLDI (CRDO)

KYG254571055 - Common Stock

73.02  -2.26 (-3%)

After market: 73.1 +0.08 (+0.11%)

Fundamental Rating

5

CRDO gets a fundamental rating of 5 out of 10. The analysis compared the fundamentals against 108 industry peers in the Semiconductors & Semiconductor Equipment industry. While CRDO has a great health rating, there are worries on its profitability. CRDO is valued quite expensively, but it does show have an excellent growth rating.



1

1. Profitability

1.1 Basic Checks

CRDO had positive earnings in the past year.
CRDO had a positive operating cash flow in the past year.
CRDO had negative earnings in each of the past 5 years.
CRDO had negative operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of -3.73%, CRDO is doing worse than 66.36% of the companies in the same industry.
CRDO has a worse Return On Equity (-4.19%) than 64.49% of its industry peers.
Industry RankSector Rank
ROA -3.73%
ROE -4.19%
ROIC N/A
ROA(3y)-4.92%
ROA(5y)-6.49%
ROE(3y)-5.55%
ROE(5y)-7.19%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

CRDO has a better Gross Margin (63.24%) than 87.85% of its industry peers.
In the last couple of years the Gross Margin of CRDO has declined.
CRDO does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 63.24%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.74%
GM growth 5YN/A

8

2. Health

2.1 Basic Checks

CRDO does not have a ROIC to compare to the WACC, probably because it is not profitable.
CRDO has more shares outstanding than it did 1 year ago.
CRDO has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.

2.2 Solvency

CRDO has an Altman-Z score of 104.51. This indicates that CRDO is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 104.51, CRDO belongs to the best of the industry, outperforming 98.13% of the companies in the same industry.
There is no outstanding debt for CRDO. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 104.51
ROIC/WACCN/A
WACC14.66%

2.3 Liquidity

CRDO has a Current Ratio of 10.84. This indicates that CRDO is financially healthy and has no problem in meeting its short term obligations.
The Current ratio of CRDO (10.84) is better than 98.13% of its industry peers.
CRDO has a Quick Ratio of 10.11. This indicates that CRDO is financially healthy and has no problem in meeting its short term obligations.
CRDO has a Quick ratio of 10.11. This is amongst the best in the industry. CRDO outperforms 97.20% of its industry peers.
Industry RankSector Rank
Current Ratio 10.84
Quick Ratio 10.11

8

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 2300.00% over the past year.
CRDO shows a strong growth in Revenue. In the last year, the Revenue has grown by 48.40%.
The Revenue has been growing by 48.69% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)2300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
Revenue 1Y (TTM)48.4%
Revenue growth 3Y48.69%
Revenue growth 5YN/A
Sales Q2Q%63.57%

3.2 Future

Based on estimates for the next years, CRDO will show a very strong growth in Earnings Per Share. The EPS will grow by 112.23% on average per year.
Based on estimates for the next years, CRDO will show a very strong growth in Revenue. The Revenue will grow by 47.57% on average per year.
EPS Next Y482.03%
EPS Next 2Y239.15%
EPS Next 3Y148.01%
EPS Next 5Y112.23%
Revenue Next Year102.3%
Revenue Next 2Y77.44%
Revenue Next 3Y57.62%
Revenue Next 5Y47.57%

3.3 Evolution

The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.

2

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 331.91 indicates a quite expensive valuation of CRDO.
The rest of the industry has a similar Price/Earnings ratio as CRDO.
When comparing the Price/Earnings ratio of CRDO to the average of the S&P500 Index (27.34), we can say CRDO is valued expensively.
A Price/Forward Earnings ratio of 70.54 indicates a quite expensive valuation of CRDO.
Based on the Price/Forward Earnings ratio, CRDO is valued a bit more expensive than the industry average as 60.75% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 23.61. CRDO is valued rather expensively when compared to this.
Industry RankSector Rank
PE 331.91
Fwd PE 70.54

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
CRDO's earnings are expected to grow with 148.01% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.69
PEG (5Y)N/A
EPS Next 2Y239.15%
EPS Next 3Y148.01%

0

5. Dividend

5.1 Amount

CRDO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

CREDO TECHNOLOGY GROUP HOLDI

NASDAQ:CRDO (1/8/2025, 8:00:00 PM)

After market: 73.1 +0.08 (+0.11%)

73.02

-2.26 (-3%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)12-02 2024-12-02/amc
Earnings (Next)N/A N/A
Inst Owners75%
Inst Owner ChangeN/A
Ins Owners16.08%
Ins Owner Change-1.32%
Market Cap12.21B
Analysts83.16
Price Target75.14 (2.9%)
Short Float %5.06%
Short Ratio2.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)12.68%
Min EPS beat(2)-4.12%
Max EPS beat(2)29.49%
EPS beat(4)3
Avg EPS beat(4)21.26%
Min EPS beat(4)-4.12%
Max EPS beat(4)32.26%
EPS beat(8)6
Avg EPS beat(8)77.02%
EPS beat(12)9
Avg EPS beat(12)212.05%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)1
Avg Revenue beat(2)2.03%
Min Revenue beat(2)-1.68%
Max Revenue beat(2)5.73%
Revenue beat(4)1
Avg Revenue beat(4)0.54%
Min Revenue beat(4)-1.85%
Max Revenue beat(4)5.73%
Revenue beat(8)4
Avg Revenue beat(8)0.42%
Revenue beat(12)6
Avg Revenue beat(12)0.74%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)82.51%
PT rev (3m)105.15%
EPS NQ rev (1m)0%
EPS NQ rev (3m)1.35%
EPS NY rev (1m)42.13%
EPS NY rev (3m)43.17%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)1.4%
Revenue NY rev (1m)22.27%
Revenue NY rev (3m)22.33%
Valuation
Industry RankSector Rank
PE 331.91
Fwd PE 70.54
P/S 49.73
P/FCF N/A
P/OCF 1979.23
P/B 21.5
P/tB 21.5
EV/EBITDA N/A
EPS(TTM)0.22
EY0.3%
EPS(NY)1.04
Fwd EY1.42%
FCF(TTM)-0.18
FCFYN/A
OCF(TTM)0.04
OCFY0.05%
SpS1.47
BVpS3.4
TBVpS3.4
PEG (NY)0.69
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -3.73%
ROE -4.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 63.24%
FCFM N/A
ROA(3y)-4.92%
ROA(5y)-6.49%
ROE(3y)-5.55%
ROE(5y)-7.19%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.74%
GM growth 5YN/A
F-Score6
Asset Turnover0.38
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 220.95%
Cap/Sales 14.7%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 10.84
Quick Ratio 10.11
Altman-Z 104.51
F-Score6
WACC14.66%
ROIC/WACCN/A
Cap/Depr(3y)236.32%
Cap/Depr(5y)293.96%
Cap/Sales(3y)12.13%
Cap/Sales(5y)12.63%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)2300%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%600%
EPS Next Y482.03%
EPS Next 2Y239.15%
EPS Next 3Y148.01%
EPS Next 5Y112.23%
Revenue 1Y (TTM)48.4%
Revenue growth 3Y48.69%
Revenue growth 5YN/A
Sales Q2Q%63.57%
Revenue Next Year102.3%
Revenue Next 2Y77.44%
Revenue Next 3Y57.62%
Revenue Next 5Y47.57%
EBIT growth 1Y10.59%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year3583.63%
EBIT Next 3Y364.03%
EBIT Next 5Y221.27%
FCF growth 1Y-0.15%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y196.86%
OCF growth 3YN/A
OCF growth 5YN/A